• 1
    Buckner CD. Autologous bone marrow transplants to hematopoietic stem cell support with peripheral blood stem cells: A historical perspective. J Hematother 1999; 8: 233236.
  • 2
    To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood 1997; 89: 22332258.
  • 3
    Sutherland DR, Keating A. The CD34 antigen: Structure, biology and potential clinical applications. J Hematother 1992; 1: 115129.
  • 4
    Lanza R, Healy L, Sutherland DR. Structural and functional features of the CD34 antigen: An update. J Biol Regul Homeost Agents 2001; 15: 113.
  • 5
    Chapple P, Prince HM, Quinn M, Bertoncello I, Juneja S, Wolf M, Januszewicz H, Brettell M, Gardyn J, Seymour C, et al. Peripheral blood CD34+ cell count reliably predicts autograft yield. Bone Marrow Transplant 1998; 22: 125130.
  • 6
    Luider J, Brown C, Selinger S, Quinlan D, Karlsson L, Ruether D, Stewart D, Klassen J, Russell JA. Factors influencing yields of progenitor cells for allogeneic transplantation: Optimization of G-CSF dose, day of collection, and duration of leukapheresis. J Hematother 1997; 6: 575580.
  • 7
    Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 19051914.
  • 8
    Siena S, Bregni M, Belli N, Brando B, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400409.
  • 9
    Bender JG, Unverzagt K. Flow cytometric analysis of peripheral blood stem cells. J Hematother 1993; 2: 421430.
  • 10
    Kreissig C, Kirsch A, Serke S. Characterization and measurement of CD34-expressing hematopoietic cells. J Hematother 1994; 3: 263289.
  • 11
    Lowdell MW, Bainbridge DR. External quality assurance for CD34 cell enumeration-results of a preliminary national trial. Royal Microscopical Society Clinical Flow Cytometry Group QA Schemes. Bone Marrow Transplant 1996; 17: 849853.
  • 12
    Johnsen H, Knudsen LM. Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: Report from the second Nordic workshop. Nordic Stem Cell Laboratory Group (NSCL-G). J Hematother 1996; 5: 237245.
  • 13
    Gratama JW, Kraan J, Levering W, Van Bockstaele DR, Rijkers GT, Van der Schoot CE. Analysis of variation in results of CD34+ hematopoietic progenitor cell enumeration in a multicenter study. Cytometry 1997; 30: 109117.
  • 14
    Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994; 22: 10031010.
  • 15
    Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE Guidelines For CD34+ Cell Determination By Flow Cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 3: 213226.
  • 16
    Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998; 34: 6170.
  • 17
    Marti GE, Johnsen HE, Sutherland DR, Serke S. A convergence of methods for a world wide standard for CD34+ cell enumeration. Letter to the Editor. J Hematother 1998; 7: 105109.
  • 18
    Barnett D, Granger V, Whitby L, Storie I, Reilly JT. Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single platform flow cytometry: The way forward. Br J Haematol 1999; 106: 10591062.
  • 19
    Barnett D, Janossy G, Lubenko A, Matutes E, Newland A, Reilly JT. For and on behalf of the BCSH. Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Clin Lab Haematol 1999; 21: 301308.
  • 20
    Gutensohn K, Carrero I, Krueger W, Kroeger N, Schafer P, Luedemann K, Kuehnl P. Semi-automated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products. Transfusion 1999; 39: 12201226.
  • 21
    Gratama JW, Orfao A, Barnett D, Brando B, Huber A, Janossy G, Johnsen HE, Keeney M, Marti G, Preijers F, et al. Flow cytometric enumeration of CD34+ hematopoietic progenitor cells. Cytometry 1998; 34: 128142.
  • 22
    Sutherland DR, Keeney M, Gratama JW. Enumeration of CD34+ Hematopoietic Stem and Progenitor Cells. In: Robinson JP, Darzynkiewicz Z, Dean PN, Dressler LG, Rabinovitch PS, Stewart CS, Tanke HJ, Wheeless LL, editors. Current Protocols in Cytometry. New York: Wiley; 2003. p
  • 23
    Gratama JW, Kraan J, Keeney M, Mandy F, Sutherland DR, Wood BL. Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline–Second Edition. Clinical and Laboratory Standards Institute, (formerly NCCLS). Document H42-A2 Volume 27 No.16, published June 2007.
  • 24
    Sutherland DR, Keeney M. Enumeration of CD34+ cells by Flow Cytometry. In: Aremen EM, Loper K, editors. Cellular Therapy: Principles, Methods and Regulations. An American Association of Blood Bankers Cell Therapy Technical Manual, Bethesda MD; 2009. pp 538554.
  • 25
    Sutherland DR, Nayyar R, Acton E, Giftakis A, Dean S, Mosiman VL. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto cytometers. Cytotherapy 2009; 11: 595605.
  • 26
    Barnett D, Granger V, Storie I, Peel J, Pollitt R, Smart T, Reilly JT. Quality assessment of CD34+ stem cell enumeration: Experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation. Br J Haematol 1998; 102: 553565.
  • 27
    Gratama JW, Braakman E, Kraan J, Lankheet P, Levering WH, Van Den Beemd MW, Van der Schoot CE, Wijermans P, Preijers F. Comparison of single and dual-platform assay formats for CD34+ haematopoietic progenitor cell enumeration. Clin Lab Haematol 1999; 21: 337346.
  • 28
    Barnett D, Granger V, Kraan J, Whitby L, Reilly JT, Papa S, Gratama JW. Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. CD34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA). Br J Haematol 2000; 108: 784792.
  • 29
    Sierra-Amor RI. Accreditation process of a proficiency testing provider according to ILAC G13: 2000/ISO G43-1: 1999. Clin Biochem 2009; 42: 306.
  • 30
    The International Organization for Standardization. International Standard ISO/IEC 17043. First edition 2010. Conformity assessment–General requirements for proficiency testing. Reference number ISO/IEC 17043: 2010(E).
  • 31
    Barnett D, Granger V, Mayr P, Storie I, Wilson GA, Reilly JT. Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: Results from the UK NEQAS immune monitoring scheme. Cytometry 1996; 26: 216222.